Johnson & Johnson Showcases TECNIS PureSee IOL Data
Jacksonville, Florida | April 10, 2026 Johnson & Johnson has presented new clinical data for its TECNIS PureSee™ intraocular...
Medical Device
Advertisement
Allevion Medical Gains FDA 510(k) for Vantage System
BOCA RATON, Fla., April 1, 2026 Allevion Medical™ announced that the U.S. Food and Drug Administration (FDA) has granted...
JenaValve Launches Trilogy Valve for Aortic Regurgitation
IRVINE, Calif., USA — April 1, 2026 JenaValve Technology, Inc. has announced the U.S. commercial launch of its Trilogy®...
BrainsWay FDA Approval Expands Depression Treatment Access
BURLINGTON, Mass. and JERUSALEM, March 31, 2026 BrainsWay Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
LiviWell FDA Clears Livi for Post-Intercourse Care
MOUNTAIN LAKES, NEW JERSEY, USA | March 24, 2026 LiviWell, a women’s health innovation company, has announced U.S. FDA...
Advertisements
Medtronic Secures FDA Approval for OmniaSecure Lead
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
NEXTBIOMEDICAL Launches U.S. Pivotal Trial for Nexsphere-F™ in Knee OA
SEOUL, South Korea, Oct. 13, 2025 — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), a South Korea-based innovative medical device company,...
HemoSonics Quantra System Cleared by FDA for Obstetric Bleeding
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
PharmaResearch and Laboratoires VIVACY Forge Strategic Alliance to Distribute REJURAN Across Europe
PharmaResearch, a regenerative medicine company headquartered in South Korea, has entered a strategic distribution partnership with France-based Laboratoires VIVACY,...
Phraxis Marks First Commercial Use of EndoForce Anastomotic Connector
MINNEAPOLIS, August 29, 2025 — Phraxis announced the successful completion of the first-ever commercial case using its EndoForce Anastomotic...
Advertisement
